10-K Filing

ROCKET LAB CORP CIK: 1819994 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001193125-21-100852`
Period End Date	20201231
Filing Date	20210331
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	vacq-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 21 Income Statement 4 Cash Flow Statement 23 Stockholders Equity 9

Balance Sheet 21 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$865.90K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$366.65K	USD	Point-in-time
Preferred shares, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.23M	USD	Point-in-time
Preferred shares, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investment held in Trust Account	`AssetsHeldInTrustNoncurrent`	$320.00M	USD	Point-in-time
Preferred shares, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$321.33M	USD	Point-in-time
Current liabilities accrued expenses	`AccruedLiabilitiesCurrent`	$217.40K	USD	Point-in-time
Deferred underwriting fee payable	`DeferredUnderwritingFeesPayable`	$11.20M	USD	Point-in-time
Total Liabilities	`Liabilities`	$11.42M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Class A ordinary shares subject to possible redemption, 30,482,000 shares at $10.00 per share	`TemporaryEquityCarryingAmountAttributableToParent`	$304.82M	USD	Point-in-time
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-352.62K	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	-	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$5.00M	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$321.33M	USD	Point-in-time

Income Statement 4 line items

Line Item	Tag	Value	Unit	Period
Formation and operating costs	`OperatingCostsAndExpenses`	$357.46K	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-357.46K	USD	2 Qtrs
Interest earned on investment held in Trust Account	`InvestmentIncomeInterest`	$4.85K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-352.62K	USD	2 Qtrs

Cash Flow Statement 23 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-352.62K	USD	2 Qtrs
Interest earned on investment held in Trust Account	`InvestmentIncomeInterest`	$4.85K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$366.65K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$217.40K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-506.71K	USD	2 Qtrs
Investment of cash in Trust Account	`PaymentsToAcquireInvestments`	$320.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-320.00M	USD	2 Qtrs
Proceeds from sale of Units, net of underwriting discounts paid	`ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid`	$313.60M	USD	2 Qtrs
Proceeds from sale of Private Placement Warrants	`ProceedsFromIssuanceOfPrivatePlacement`	$8.40M	USD	2 Qtrs
Proceeds from promissory note related party	`ProceedsFromRelatedPartyDebt`	$300.00K	USD	2 Qtrs
Repayment of promissory note related party	`RepaymentsOfRelatedPartyDebt`	$300.00K	USD	2 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$627.38K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$321.37M	USD	2 Qtrs
Net Change in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$865.90K	USD	2 Qtrs
Cash Beginning	`CashAndCashEquivalentsAtCarryingValue`	$865.90K	USD	Point-in-time
Cash Beginning	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash Ending	`CashAndCashEquivalentsAtCarryingValue`	$865.90K	USD	Point-in-time
Cash Ending	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Initial classification of Class A ordinary shares subject to possible redemption	`InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption`	$305.15M	USD	2 Qtrs
Change in value of Class A ordinary shares subject to possible redemption	`ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption`	$-333.76K	USD	2 Qtrs
Deferred underwriting fee payable	`DeferredUnderwritingFeePayable`	$11.20M	USD	2 Qtrs
Deferred offering costs paid directly by Sponsor from proceeds of issuance of Class B ordinary shares	`DeferredOfferingCostsPaidDirectlyBySponsorFromProceedsOfIssuanceOfClassBOrdinaryShares`	$25.00K	USD	2 Qtrs
Forfeiture of Founder Shares	`ForfeitureOfFounderShares`	$-68.00	USD	2 Qtrs

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Balance at Beginning	`StockholdersEquity`	-	USD	Point-in-time
Balance at Beginning	`StockholdersEquity`	$5.00M	USD	Point-in-time
Issuance of Class B ordinary shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	2 Qtrs
Sale of 32,000,000 Units, net of underwriting discounts and offering costs	`SaleOfNetOfUnderwritingDiscountsAndOfferingCosts`	$301.75M	USD	2 Qtrs
Sale of 5,600,000 Private Placement Warrants	`SaleOfPrivatePlacementWarrants`	$8.40M	USD	2 Qtrs
Ordinary shares subject to possible redemption	`StockRedeemedOrCalledDuringPeriodValue`	$304.82M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-352.62K	USD	2 Qtrs
Balance Ending	`StockholdersEquity`	-	USD	Point-in-time
Balance Ending	`StockholdersEquity`	$5.00M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.